Skip to content

Clover Health Investments CLOV Issuance of common stock, net of early exercise liability

Issuance of common stock, net of early exercise liability at other companies

Cohen & Steers logo
Cohen & SteersCNS
$0-100%
Sabra Healthcare logo
Sabra HealthcareSBRA
-$8.25M-53.0%
TRN
Terreno RealtyTRNO
$2.12M+1,327%
Macerich logo
MacerichMAC
-$60.54M-14,583%
LXP Industrial Trust logo
LXP Industrial TrustLXP
-$3.15M-203%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$73.5K

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept clov:ProceedsFromIssuanceOfCommonStockNetOfEarlyExerciseLiability.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's issuance of common stock, net of early exercise liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's issuance of common stock, net of early exercise liability?
Clover Health Investments (CLOV) reported issuance of common stock, net of early exercise liability of $30K in Q1 2026.
How has Clover Health Investments's issuance of common stock, net of early exercise liability changed year-over-year?
Clover Health Investments's issuance of common stock, net of early exercise liability decreased by 86.0% year-over-year, from $215K to $30K.
What is the long-term trend for Clover Health Investments's issuance of common stock, net of early exercise liability?
Over 3 years (2021 to 2025), Clover Health Investments's issuance of common stock, net of early exercise liability has grown at a -51.1% compound annual growth rate (CAGR), from $6.14M to $718K.
What does issuance of common stock, net of early exercise liability mean?
This metric represents the net cash inflows received by the company from the issuance of common equity, adjusted for any early exercise liabilities. It reflects the capital raised through primary equity offerings or employee stock purchase programs after accounting for associated issuance costs. This figure serves as a key indicator of the company's ability to access public equity markets to bolster its capital base.